Your browser doesn't support javascript.
loading
Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
Wang, Lawrence T; Pereira, Lais S; Kiyuka, Patience K; Schön, Arne; Kisalu, Neville K; Vistein, Rachel; Dillon, Marlon; Bonilla, Brian G; Molina-Cruz, Alvaro; Barillas-Mury, Carolina; Tan, Joshua; Idris, Azza H; Francica, Joseph R; Seder, Robert A.
Affiliation
  • Wang LT; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Pereira LS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Kiyuka PK; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Schön A; Department of Biological Sciences, Pwani University, Kilifi, Kenya.
  • Kisalu NK; Department of Biology, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Vistein R; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Dillon M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Bonilla BG; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Molina-Cruz A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Barillas-Mury C; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
  • Tan J; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
  • Idris AH; Antibody Biology Unit, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
  • Francica JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Seder RA; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, United States of America.
PLoS Pathog ; 17(12): e1010133, 2021 12.
Article in En | MEDLINE | ID: mdl-34871332
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium falciparum / Protozoan Proteins / Immunization, Passive / Malaria Vaccines / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: PLoS Pathog Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium falciparum / Protozoan Proteins / Immunization, Passive / Malaria Vaccines / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: PLoS Pathog Year: 2021 Document type: Article Affiliation country: Country of publication: